Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
Just nowPress Release Apr 29 2026
Just nowPress Release Apr 29 2026
Just nowPress Release Apr 29 2026
Just nowPress Release Apr 29 2026
Just nowPress Release Apr 29 2026
Biovie Inc logo

Biovie Inc

About

Biovie Inc (NASDAQ:BIVI) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 27 2026
BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson's Disease ahead of Topline Data in 2Q26, on May 7, 2026
Apr 14 2026
BioVie Announces Abstract Accepted for Presentation at the 2026 American Academy of Neurology Annual Meeting
Mar 12 2026
BioVie Announces Abstract Accepted for Presentation at AD/PD 2026
Feb 23 2026
Join Biovie’s Exclusive Live Investor Webinar and Q&A Session on March 4
Feb 12 2026
BioVie Announces Abstracts Accepted for Presentation at the 2026 American College of Psychiatrists Annual Meeting

Financials

Revenue
$0
Market Cap
$10.71 M
EPS
-3.28

Community Chat

Ask AI

6ix6ix